# Nautilus Biotechnology, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:0e1028ca-1667-45de-91f2-95823f879caf | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/nautilus-biotechnology-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 31 | | Claims under review | 1 | | Evidence records | 9 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-17T04:46:35.948617+00:00 | | Last reviewed | 2026-10-17T04:46:35.948617+00:00 | ## Identity - Legal name: Nautilus Biotechnology, Inc. - Display name: Nautilus Biotechnology, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T06:06:34.308362+00:00 | | Completeness | 0.409 | | Record Quality | 0.842 | | Directors | 10 | | Committees | 5 | | Governance events | 19 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Farzad Nazem: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:leadership_role:5 - Karen Akinsanya: Director. Status: current. Independent: true. Since: 2022-01-01. claim_id=alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:leadership_role:6 - Matthew McIlwain: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Audit (member); Audit; Nominating and Governance · Chair (member); Nominating and Governance (chair). claim_id=alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:leadership_role:7 - Melissa Epperly: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Audit (chair); Audit · Chair; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:leadership_role:8 - Michael Altman: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:leadership_role:9 - Parag Mallick: Director. Status: current. Independent: false. Since: 2021-01-01. claim_id=alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:leadership_role:10 - Sujal Patel: Director. Status: current. Independent: false. Since: 2021-01-01. claim_id=alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:leadership_role:11 - Vijay Pande: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Nominating and Governance (member). claim_id=alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:leadership_role:12 - Karen Akinsanya: Director (committee appointment). Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. Committees: Compensation (member). claim_id=alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:committee_record:23 - Matthew L. Posard: Director (committee appointment). Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. Committees: Audit (member); Compensation (chair). claim_id=alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:committee_record:19 ## Committees - Audit (audit). Chair: Melissa Epperly. Members: Melissa Epperly (chair, current); Matthew L. Posard (member, current); Matthew McIlwain (member, current). committee_id=alpha:committee:nautilus-biotechnology-inc:audit - Audit · Chair; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Melissa Epperly (member, current). committee_id=alpha:committee:nautilus-biotechnology-inc:audit-chair-nominating-and-governance - Audit; Nominating and Governance · Chair (audit). Chair: NOT_PUBLISHED. Members: Matthew McIlwain (member, current). committee_id=alpha:committee:nautilus-biotechnology-inc:audit-nominating-and-governance-chair - Compensation (compensation). Chair: Matthew L. Posard. Members: Matthew L. Posard (chair, current); Farzad Nazem (member, current); Karen Akinsanya (member, current); Michael Altman (member, current). committee_id=alpha:committee:nautilus-biotechnology-inc:compensation - Nominating and Governance (nominating_governance). Chair: Matthew McIlwain. Members: Matthew McIlwain (chair, current); Melissa Epperly (member, current); Vijay Pande (member, current). committee_id=alpha:committee:nautilus-biotechnology-inc:nominating-and-governance ## Executive leadership - Anna Mowry: Chief Financial Officer and Treasurer [CFO]. Status: current. claim_id=alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:leadership_role:13 - Gwen Weld: Chief People Officer [CHRO]. Status: current. claim_id=alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:leadership_role:14 - Kentaro Suzuki: Chief Marketing Officer. Status: current. claim_id=alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:leadership_role:15 - Matthew Murphy: General Counsel [GC]. Status: current. claim_id=alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:leadership_role:16 - Subra Sankar: Senior Vice President, Product Development. Status: current. claim_id=alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:leadership_role:17 - Sujal Patel: Chief Executive Officer, President, Secretary and Director [CEO]. Status: current. claim_id=alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:leadership_role:18 ## Governance events - CFO_CHANGED: Anna Mowry executive of Nautilus Biotechnology, Inc., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-17T04:46:35.948617+00:00. event_id=alpha:event:transition:cc1d351vuz2vd - EXECUTIVE_APPOINTED: Gwen Weld executive of Nautilus Biotechnology, Inc., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-17T04:46:35.948617+00:00. event_id=alpha:event:transition:3p60i45385r8 - EXECUTIVE_APPOINTED: Kentaro Suzuki executive of Nautilus Biotechnology, Inc., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-17T04:46:35.948617+00:00. event_id=alpha:event:transition:7oaowhd29rqb - GC_CHANGED: Matthew Murphy executive of Nautilus Biotechnology, Inc., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-17T04:46:35.948617+00:00. event_id=alpha:event:transition:1h7zh211ydj8w3 - EXECUTIVE_APPOINTED: Subra Sankar executive of Nautilus Biotechnology, Inc., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-17T04:46:35.948617+00:00. event_id=alpha:event:transition:1er1v1x1odif07 - CEO_CHANGED: Sujal Patel executive of Nautilus Biotechnology, Inc., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-17T04:46:35.948617+00:00. event_id=alpha:event:transition:1mky1qj1jmofl1 - DIRECTOR_APPOINTED: Karen Akinsanya seat on Nautilus Biotechnology, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:46:35.948617+00:00. event_id=alpha:event:transition:17s4yrhc297o1 - DIRECTOR_APPOINTED: Farzad Nazem seat on Nautilus Biotechnology, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:35.948617+00:00. event_id=alpha:event:transition:1dwkfa9l2bd6x - DIRECTOR_APPOINTED: Matthew McIlwain seat on Nautilus Biotechnology, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:35.948617+00:00. event_id=alpha:event:transition:12fop5355hbib - DIRECTOR_APPOINTED: Melissa Epperly seat on Nautilus Biotechnology, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:35.948617+00:00. event_id=alpha:event:transition:9h9lc2x8f34w - DIRECTOR_APPOINTED: Michael Altman seat on Nautilus Biotechnology, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:35.948617+00:00. event_id=alpha:event:transition:1k3qb751rsp4mt - DIRECTOR_APPOINTED: Parag Mallick seat on Nautilus Biotechnology, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:35.948617+00:00. event_id=alpha:event:transition:1fm11lv1bv6cc1 - DIRECTOR_APPOINTED: Sujal Patel seat on Nautilus Biotechnology, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:35.948617+00:00. event_id=alpha:event:transition:1wipta61xxlzvk - DIRECTOR_APPOINTED: Vijay Pande seat on Nautilus Biotechnology, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:35.948617+00:00. event_id=alpha:event:transition:1eetutrxf9p9r - COMMITTEE_CREATED: Audit · Chair; Nominating and Governance committee of Nautilus Biotechnology, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:35.948617+00:00. event_id=alpha:event:transition:10m33uw174qyw4 - COMMITTEE_MEMBER_ADDED: Melissa Epperly member of Audit · Chair; Nominating and Governance, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:35.948617+00:00. event_id=alpha:event:transition:tckwsn1ps60vz - COMMITTEE_CREATED: Audit; Nominating and Governance · Chair committee of Nautilus Biotechnology, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:35.948617+00:00. event_id=alpha:event:transition:1stkfprep02yb - COMMITTEE_MEMBER_ADDED: Matthew McIlwain member of Audit; Nominating and Governance · Chair, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:35.948617+00:00. event_id=alpha:event:transition:1n2iej0xm4a9c - COMMITTEE_MEMBER_ADDED: Farzad Nazem member of Compensation, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:35.948617+00:00. event_id=alpha:event:transition:14d3til1o6xuih ## Scoped resources - `alpha://company/nautilus-biotechnology-inc` (contract): https://registry.alpha.ac/api/public/companies/nautilus-biotechnology-inc?format=record - `alpha://company/nautilus-biotechnology-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/nautilus-biotechnology-inc?format=record§ion=identity - `alpha://company/nautilus-biotechnology-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/nautilus-biotechnology-inc?format=record§ion=corporate-structure - `alpha://company/nautilus-biotechnology-inc/board` (contract): https://registry.alpha.ac/api/public/companies/nautilus-biotechnology-inc?format=record§ion=board - `alpha://company/nautilus-biotechnology-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/nautilus-biotechnology-inc?format=record§ion=committees - `alpha://company/nautilus-biotechnology-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/nautilus-biotechnology-inc?format=record§ion=leadership - `alpha://company/nautilus-biotechnology-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/nautilus-biotechnology-inc?format=record§ion=ownership - `alpha://company/nautilus-biotechnology-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/nautilus-biotechnology-inc?format=record§ion=financials - `alpha://company/nautilus-biotechnology-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/nautilus-biotechnology-inc?format=record§ion=capital-structure - `alpha://company/nautilus-biotechnology-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/nautilus-biotechnology-inc?format=record§ion=compensation - `alpha://company/nautilus-biotechnology-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/nautilus-biotechnology-inc?format=record§ion=governance - `alpha://company/nautilus-biotechnology-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/nautilus-biotechnology-inc?format=record§ion=shareholder-governance - `alpha://company/nautilus-biotechnology-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/nautilus-biotechnology-inc?format=record§ion=audit - `alpha://company/nautilus-biotechnology-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/nautilus-biotechnology-inc?format=record§ion=legal - `alpha://company/nautilus-biotechnology-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/nautilus-biotechnology-inc?format=record§ion=risk - `alpha://company/nautilus-biotechnology-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/nautilus-biotechnology-inc?format=record§ion=cyber - `alpha://company/nautilus-biotechnology-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/nautilus-biotechnology-inc?format=record§ion=ai-governance - `alpha://company/nautilus-biotechnology-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/nautilus-biotechnology-inc?format=record§ion=agents - `alpha://company/nautilus-biotechnology-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/nautilus-biotechnology-inc?format=record§ion=ecosystem - `alpha://company/nautilus-biotechnology-inc/events` (contract): https://registry.alpha.ac/api/public/companies/nautilus-biotechnology-inc?format=record§ion=events - `alpha://company/nautilus-biotechnology-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/nautilus-biotechnology-inc?format=record§ion=relationships - `alpha://company/nautilus-biotechnology-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/nautilus-biotechnology-inc?format=record§ion=assessments - `alpha://company/nautilus-biotechnology-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/nautilus-biotechnology-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:melissa-epperly","name":"Melissa Epperly"},"source_id":"board_seats"}` - Claim alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:matthew-l-posard","name":"Matthew L. Posard"},"source_id":"board_seats"}` - Claim alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:matthew-mcilwain","name":"Matthew McIlwain"},"source_id":"board_seats"}` - Claim alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:matthew-l-posard","name":"Matthew L. Posard"},"source_id":"board_seats"}` - Claim alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:committee_appointment:25: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:farzad-nazem","name":"Farzad Nazem"},"source_id":"board_seats"}` - Claim alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:karen-akinsanya","name":"Karen Akinsanya"},"source_id":"board_seats"}` - Claim alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:committee_appointment:27: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:michael-altman","name":"Michael Altman"},"source_id":"board_seats"}` - Claim alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:committee_appointment:29: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:matthew-mcilwain","name":"Matthew McIlwain"},"source_id":"board_seats"}` - Claim alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:committee_appointment:30: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:melissa-epperly","name":"Melissa Epperly"},"source_id":"board_seats"}` - Claim alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:committee_appointment:31: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:vijay-pande","name":"Vijay Pande"},"source_id":"board_seats"}` ## Leadership - Farzad Nazem: Director, Compensation. Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:leadership_role:5. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:da598049201e9da818cfd2042429f54d92e6bc367efe1013f9132f04f8d6cf09. - Karen Akinsanya: Director. Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:leadership_role:6. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:da598049201e9da818cfd2042429f54d92e6bc367efe1013f9132f04f8d6cf09. - Matthew McIlwain: Director, Audit; Nominating and Governance · Chair. Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:leadership_role:7. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:da598049201e9da818cfd2042429f54d92e6bc367efe1013f9132f04f8d6cf09. - Melissa Epperly: Director, Audit · Chair; Nominating and Governance. Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:leadership_role:8. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:da598049201e9da818cfd2042429f54d92e6bc367efe1013f9132f04f8d6cf09. - Michael Altman: Director, Compensation. Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:leadership_role:9. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:da598049201e9da818cfd2042429f54d92e6bc367efe1013f9132f04f8d6cf09. - Parag Mallick: Director. Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:leadership_role:10. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:da598049201e9da818cfd2042429f54d92e6bc367efe1013f9132f04f8d6cf09. - Sujal Patel: Director. Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:leadership_role:11. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:da598049201e9da818cfd2042429f54d92e6bc367efe1013f9132f04f8d6cf09. - Vijay Pande: Director, Nominating and Governance. Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:leadership_role:12. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:da598049201e9da818cfd2042429f54d92e6bc367efe1013f9132f04f8d6cf09. - Anna Mowry: Chief Financial Officer and Treasurer. Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:leadership_role:13. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b0536c7b61f23845637478f9d6fa2233e4deba56f5230bdea9e1bde92a9a7600. - Gwen Weld: Chief People Officer. Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:leadership_role:14. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:eebe1dfd155f3dd412c8178ec5a8c4706f59f3365f906c1a6d12df00f95315d4. - Kentaro Suzuki: Chief Marketing Officer. Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:leadership_role:15. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:566b669bdbbc5c2399a561ed8a8865ec1efa72dd3ecea19fe0b17893b6c528b1. - Matthew Murphy: General Counsel. Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:leadership_role:16. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:197c6d4e8831331eb96aa922a80e0adb76a507e31f3f930efbd2d7dae08b8859. - Subra Sankar: Senior Vice President, Product Development. Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:leadership_role:17. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:987cc6bf4ee39f6cbb32819fb75da546ddf3c72aed57f8f2225fb7db815fd5e4. - Sujal Patel: Chief Executive Officer, President, Secretary and Director. Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:leadership_role:18. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5bbe65e3cf2b9164ca02597fc9ad67e506d842bc3c08b26cba8227e5ccb4e978. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Melissa Epperly; Members Melissa Epperly (Chair); Matthew L. Posard; Matthew McIlwain. Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:committee_record:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c23d3d7801211d163be33daea588aa9966e81984cdd301718d92a3f7ff7a80f5. - Compensation: Chair Matthew L. Posard; Members Matthew L. Posard (Chair); Farzad Nazem; Karen Akinsanya; Michael Altman. Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:committee_record:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c23d3d7801211d163be33daea588aa9966e81984cdd301718d92a3f7ff7a80f5. - Nominating and Governance: Chair Matthew McIlwain; Members Matthew McIlwain (Chair); Melissa Epperly; Vijay Pande. Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:committee_record:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c23d3d7801211d163be33daea588aa9966e81984cdd301718d92a3f7ff7a80f5. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Nautilus Biotechnology, Inc.. Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:5900b6a1501ffb6cc5664169172c183023c2caafe6208460b1b56c30a35cf3f9. ## Entity Status - Public listing published. Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:5900b6a1501ffb6cc5664169172c183023c2caafe6208460b1b56c30a35cf3f9. ## Published Fact - US. Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:5900b6a1501ffb6cc5664169172c183023c2caafe6208460b1b56c30a35cf3f9. ## Committee Appointment - Melissa Epperly: chair, Audit. Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c23d3d7801211d163be33daea588aa9966e81984cdd301718d92a3f7ff7a80f5. - Matthew L. Posard: member, Audit. Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c23d3d7801211d163be33daea588aa9966e81984cdd301718d92a3f7ff7a80f5. - Matthew McIlwain: member, Audit. Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c23d3d7801211d163be33daea588aa9966e81984cdd301718d92a3f7ff7a80f5. - Matthew L. Posard: chair, Compensation. Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c23d3d7801211d163be33daea588aa9966e81984cdd301718d92a3f7ff7a80f5. - Farzad Nazem: member, Compensation. Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:committee_appointment:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c23d3d7801211d163be33daea588aa9966e81984cdd301718d92a3f7ff7a80f5. - Karen Akinsanya: member, Compensation. Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c23d3d7801211d163be33daea588aa9966e81984cdd301718d92a3f7ff7a80f5. - Michael Altman: member, Compensation. Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c23d3d7801211d163be33daea588aa9966e81984cdd301718d92a3f7ff7a80f5. - Matthew McIlwain: chair, Nominating and Governance. Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:committee_appointment:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c23d3d7801211d163be33daea588aa9966e81984cdd301718d92a3f7ff7a80f5. - Melissa Epperly: member, Nominating and Governance. Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:committee_appointment:30. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c23d3d7801211d163be33daea588aa9966e81984cdd301718d92a3f7ff7a80f5. - Vijay Pande: member, Nominating and Governance. Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:committee_appointment:31. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c23d3d7801211d163be33daea588aa9966e81984cdd301718d92a3f7ff7a80f5. ## Security Listing - NAUT (NASDAQ). Claim: alpha:claim:company:0e1028ca-1667-45de-91f2-95823f879caf:security_listing:32. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:5900b6a1501ffb6cc5664169172c183023c2caafe6208460b1b56c30a35cf3f9. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:5900b6a1501ffb6cc5664169172c183023c2caafe6208460b1b56c30a35cf3f9: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/nautilus-biotechnology-inc). - alpha:projection-evidence:document:da598049201e9da818cfd2042429f54d92e6bc367efe1013f9132f04f8d6cf09: [Nautilus Biotechnology, Inc. DEF 14A 2025-04-29](https://www.sec.gov/Archives/edgar/data/1808805/000180880525000043/nautilusdef14a20250620a.htm). - alpha:projection-evidence:document:b0536c7b61f23845637478f9d6fa2233e4deba56f5230bdea9e1bde92a9a7600: [NAUT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1808805/000180880526000023/nautilusdef14a20260617a.htm). - alpha:projection-evidence:document:eebe1dfd155f3dd412c8178ec5a8c4706f59f3365f906c1a6d12df00f95315d4: [NAUT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1808805/000180880526000023/nautilusdef14a20260617a.htm). - alpha:projection-evidence:document:566b669bdbbc5c2399a561ed8a8865ec1efa72dd3ecea19fe0b17893b6c528b1: [NAUT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1808805/000180880526000023/nautilusdef14a20260617a.htm). - alpha:projection-evidence:document:197c6d4e8831331eb96aa922a80e0adb76a507e31f3f930efbd2d7dae08b8859: [NAUT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1808805/000180880526000023/nautilusdef14a20260617a.htm). - alpha:projection-evidence:document:987cc6bf4ee39f6cbb32819fb75da546ddf3c72aed57f8f2225fb7db815fd5e4: [NAUT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1808805/000180880526000023/nautilusdef14a20260617a.htm). - alpha:projection-evidence:document:5bbe65e3cf2b9164ca02597fc9ad67e506d842bc3c08b26cba8227e5ccb4e978: [NAUT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1808805/000180880526000023/nautilusdef14a20260617a.htm). - alpha:projection-evidence:c23d3d7801211d163be33daea588aa9966e81984cdd301718d92a3f7ff7a80f5: [Audit](https://www.sec.gov/Archives/edgar/data/1808805/000180880525000043/nautilusdef14a20250620a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/nautilus-biotechnology-inc) - [Public Markdown](https://registry.alpha.ac/companies/nautilus-biotechnology-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/nautilus-biotechnology-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/nautilus-biotechnology-inc?format=jsonld) - MCP resource: `alpha://companies/nautilus-biotechnology-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T06:06:34.076693+00:00; recorded 2026-10-17T06:06:34.076693+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.